Robert Lenz
Fortune : 571 820 $ au 31/05/2026
Fortune : 571 820 $ au 31/05/2026
Robert A. Lenz is currently Co-Managing Director at Lenz, Kämper GmbH & Co. KG.
He is also an Independent Director at LB Pharmaceuticals, Inc. starting in 2026 and an Independent Director at NovaBridge Biosciences starting in 2025.
Formerly, Dr. Lenz was Senior Vice President & Head-Global Development at Amgen, Inc. and Head-Research & Development at Neumora Therapeutics, Inc. Dr. Lenz earned a doctorate from the University of Maryland and completed undergraduate studies at Dickinson College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/02/2025 | 309 092 ( 0,17 % ) | 571 820 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Directeur/Membre du Conseil | 22/08/2025 |
| LB PHARMACEUTICALS INC | Directeur/Membre du Conseil | 06/03/2026 |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Producer Manufacturing |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national